A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. [PDF]
Kraus MH, Yuasa Y, Aaronson SA.
europepmc +1 more source
Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer. [PDF]
Li T +12 more
europepmc +1 more source
Antibody of predetermined specificity to a carboxy-terminal region of H-ras gene products inhibits their guanine nucleotide-binding function. [PDF]
Srivastava SK +3 more
europepmc +1 more source
Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. [PDF]
Reynolds SH +4 more
europepmc +1 more source
Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. [PDF]
Wiseman RW +4 more
europepmc +1 more source
Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes. [PDF]
Nakano H +5 more
europepmc +1 more source
Activation of N-ras in a human melanoma cell line. [PDF]
Padua RA, Barrass NC, Currie GA.
europepmc +1 more source
Localisation of the human N-ras oncogene to chromosome 1cen - p21 by in situ hybridisation. [PDF]
Davis M, Malcolm S, Hall A, Marshall CJ.
europepmc +1 more source
In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells. [PDF]
Gonen B, Kahana O, Witz IP.
europepmc +1 more source
Characterization of mutagen-activated cellular oncogenes that confer anchorage independence to human fibroblasts and tumorigenicity to NIH 3T3 cells: sequence analysis of an enzymatically amplified mutant HRAS allele. [PDF]
Stevens CW, Manoharan TH, Fahl WE.
europepmc +1 more source

